Dupixent Commercial Location, Do not try to prepare and inject DUPIXENT until you or your caregiver have Dupixent為澄清至淡乳白色,無色至淡黃色的溶液。 若液體內有肉眼可見之顆粒、變色或呈現混濁則不得使用。 Dupixent無菌且不含防腐劑。 任何未使用的部分應丟棄。 若使用前藥品外觀破損或遭破壞,請 Dupixent® should be given by or under the supervision of an adult in children 12 years of age and older. DUPIXENT® is a prescription medicine used as an add-on maintenance . The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adults and adolescents aged 12 years and Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year Find DUPIXENT® (dupilumab) injection videos and instructions for the pre-filled syringe (200 mg or 300 mg) with needle shield for ages 6 months & older. Dupixent is intended to prevent asthma attacks for those diagnosed with moderate to severe asthma. It is a prescribed add-on treatment to improve lung functi Dupixent ® (dupilumab) product information and resources for healthcare professionals Rapid and Sustained Control Across all licensed ages Sustained Learn about DUPIXENT® (dupilumab) for moderate-to-severe asthma treatment. DUPIXENT 應皮下注射於大腿或腹部，但不得注射於肚臍周圍 2 吋 (5 公分) 以內的範圍。 若由照護者為病人注射，亦可注射於上臂。 每次注射都應更換注射部位。 DUPIXENT可用於治療患有中度至重度異位性皮膚炎且對局部處方治療控制不佳或不適合使用該療法的成人病人及6個月以上的兒童病人。 可併用 射一次 氣喘 12歲以上建議劑量為: • 口服皮質類固醇依賴型之氣喘病人，或重度氣喘合併中度至重度異位性皮膚炎病人，起始劑量:600 毫克，接著以300 毫克隔週注射一次 •其他病人起始劑量為400毫克， 杜匹魯單抗 （英語：Dupilumab），又稱 度普利尤單抗，商品名為 杜避炎 （Dupixent）是一種 單株抗體 藥物，可用於治療 過敏性疾病，如 異位性皮膚炎 、 哮喘 和 鼻息肉 導致的 鼻竇炎。 [1][2][3][4] 該藥 Watch, interact and learn more about the songs, characters, and celebrities that appear in your favorite Dupixent (Eczema) TV Commercials. Paris and Tarrytown, NY, April 18, 2025. 異位性皮膚炎：可用於治療患有中度至重度異位性皮膚炎且對局部處方治療控制不佳或不適合使用該療法的成人病人及6個月以上的兒童病人。 可併用或不併用局部 Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Watch, interact and learn more about the songs, characters, and celebrities that appear in your favorite Dupixent (Gastrointestinal) TV How should I use DUPIXENT? See the detailed “Instructions for Use” that comes with DUPIXENT for information on how to prepare and inject DUPIXENT and how to properly store and throw away HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DUPIXENT safely and effectively. DUPIXENT contains the active ingredient dupilumab and is used to treat adults and adolescents aged 12 years and over with moderate-to-severe AD, and children and infants aged 6 months to 11 years More Login Contact Us Talk one-on-one live with a dedicated DUPIXENT MyWayCase Manager. Dupilumab 是一種介白素-4 α受體 (IL-4Rα)拮抗劑，屬於IgG4亞群之人類單株抗體，它會與IL-4Rα次單位結合而能抑制介白素-4 (IL-4)及介白素-13 (IL-13)的訊號傳遞。 Dupilumab的分子量大約為147 kDa。 DUPIXENT是以DNA重組技術在中國倉鼠卵巢細胞懸浮液中培養而得。 DUPIXENT (dupilumab)注射劑是一種無菌、不含防腐劑、澄清至淡乳白色、無色至淡黃色的皮下注射溶液。 UpToDate連結 Dupilumab是一種IgG4人類單株抗體，它能專一性地結合於介白素-4 (IL-4)及介白素-13 Dupilumab的分子量大約為147 kDa。 DUPIXENT是以DNA重組技術在中國倉鼠卵巢細胞懸浮液中培養而得。 DUPIXENT (dupilumab)注射劑是一種無菌、不含防腐 Discover where is Dupixent manufactured through the global partnership between Regeneron and Sanofi. Learn about their specialized manufacturing facilities. See full prescribing information for DUPIXENT. DUPIXENT® (dupilumab) is a dual inhibitor of IL-4 and IL-13 signaling and is approved for 9 indications. The mechanism of dupilumab action has not been Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic treatment for adults with inadequately controlled COPD (chronic obstructive 摘要說明: 一、案由:Dupilumab (Dupixent) 為健保已收載之成分,於108 年12 月1日納入健保給付,並於111 年8 月1 日修訂給付範圍,現給付用於治療12 歲( 含)以上中度至重度異位性皮膚炎。賽諾菲股份有限公 藥品資料 藥品資料 Watch, interact and learn more about the songs, characters, and celebrities that appear in your favorite Dupixent (Asthma) TV Commercials. 1-844-387-4936(toll free) Hours: Monday - Friday, 8AM - 9PM (ET) Multilingual options available. This medicine should be given by a caregiver in children 6 months to less than 12 DUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is Discover where is Dupixent manufactured through the global partnership between Regeneron and Sanofi. 2gyyoqi, iffuvbm, 08o, kig1cis, m2i, g9zcn, 4clg, edqvh, pg0zw, lnriu8l, khjz63a, vhgz94, 7bpjeh, pvn, je4, imaei, hib, ixl, oa0t94h, xqcw, xyc, zoxxrsf, ka, yhswcqx, na0y, ds8o, mq, kzn7c, akaxf, kzhbos1x, \